Tags

Type your tag names separated by a space and hit enter

Ethosuximide

Abstract
Ethosuximide is FDA approved for the management of absence seizures in patients over 3 years of age. Currently, there are no off label uses for ethosuximide, however, there is some evidence it may have some analgesic effects. Specifically, several studies have suggested value in the management of neuropathic pain.[1][2][3]

Publisher

StatPearls Publishing
Treasure Island (FL)

Language

eng

PubMed ID

31334964

Citation

Hanrahan B, Carson RP: Ethosuximide.StatPearls. StatPearls Publishing, 2019, Treasure Island (FL).
Hanrahan B, Carson RP. Ethosuximide. StatPearls. Treasure Island (FL): StatPearls Publishing; 2019.
Hanrahan B & Carson RP. (2019). Ethosuximide. In StatPearls. Treasure Island (FL): StatPearls Publishing;
Hanrahan B, Carson RP. StatPearls. Treasure Island (FL): StatPearls Publishing; 2019.
* Article titles in AMA citation format should be in sentence-case
TY - CHAP T1 - Ethosuximide BT - StatPearls A1 - Hanrahan,Brian, AU - Carson,Robert P., Y1 - 2019/01// PY - 2019/7/24/pubmed PY - 2019/7/24/medline PY - 2019/7/24/entrez N2 - Ethosuximide is FDA approved for the management of absence seizures in patients over 3 years of age. Currently, there are no off label uses for ethosuximide, however, there is some evidence it may have some analgesic effects. Specifically, several studies have suggested value in the management of neuropathic pain.[1][2][3] PB - StatPearls Publishing CY - Treasure Island (FL) UR - https://www.unboundmedicine.com/medline/citation/31334964/StatPearls:_Ethosuximide L2 - https://www.ncbi.nlm.nih.gov/books/NBK544244 DB - PRIME DP - Unbound Medicine ER -
Unbound Prime app for iOS iPhone iPadUnbound PubMed app for AndroidAlso Available:
Unbound MEDLINE
Unbound PubMed app for Windows